Apply for the 7/2025 HCM/Sports Cardiology fellowship! Unique experience with high Patient & imaging volume, interventional/surgical expertise. Looking forward to expanding the field of experts. @RobynBrydeMD @BradLander18 @hcmsociety

He is a tough act to follow. @morristownheart

Lessons from the president at Great Wall meeting 2025 @ACCinTouch @UVACardsFellows

Have you seen the new @ACCinTouch statement on Tricuspid Regurgitation yet? 👀 If not — no worries! Join us tomorrow for a live #ACCImaging webinar with the lead authors, world-class clinicians, and expert imagers as we break it all down. 💡🫀 Register now:

Highly recommend echo update by the Mayo Clinic. Great case reports, panel discussions, imaging tips, guidelines review w outcome-impacting therapies. (And Great food!😋). Presenters are approachable/practical. Would ❤️ to attend again! Thx to the organizers & presenters!

Thank you, Melissa!

Key points slide ⬇️

Great #sportscards month, from Madrid (#EAPC) to Sau Paulo (#BSC), to Seattle (#IC25), ending in DC for #ACCLegConf 2025. So much momentum in the field from around the world. #notdoneyet @ACCinTouch @mmartinezheart @adanielianmd @MichaelPapadak2

Call #FIT #EC interested in a career in #WomensCVH please send us your work! It’s time for 2nd Annual @ISHVnews @MassGenBrigham @MassGeneralNews Women’s Heart program #YIA . Abstracts due 1/9/26!!! ❤️ 🧪 🧬 🤰

Just out - first ARENA Project paper on isolated TWI V2-3 in female athletes. In a cohort of >4,400 athletes, prevalence in females was 1.5% & this finding was not associated with pathology. Full paper: https://t.co/87Wqk8CozO Editorial: https://t.co/gS2bbj8ng0

19/Key Takeaways. ✅ HCM often goes undetected ✅ Symptoms may be vague ✅ Provoked testing is essential ✅ New therapies can reduce need for surgery ✅ Refer early

17/Don’t Miss the “Atypical” Patient. HCM is underdiagnosed in: • Women • Black patients • Older adults Bias and phenotype variability contribute to delays.

16/What’s Next in HCM? · Aficamten (next-generation myosin inhibitor): promising results in REDWOOD-HCM and SEQUOIA-HCM · Gene therapies in early trials · AI tools using ECG and echo data to identify undiagnosed HCM

14/Shared Decision Making. Involve patients in all decisions: • ICD • Exercise • Family screening • Advanced therapies Shared decision making improves outcomes.

1/22 In this #CME #MedX, @mmartinezheart provides guidance for managing HCM, from symptoms to diagnosis & treatment, and explores when oHCM may be hiding in plain sight. Participate for credit: https://t.co/VlHKrbLnWj Supported by an educational grant from Bristol Myers Squibb.

An honor to be invited! Thank you and AHA for the invitation. @AbdelfattahMD

A heavily anticipated session with 1500+ registered ! It was a privilege and delight to have @mmartinezheart with us this evening, whose expertise in HCM, sports cardilogy & advanced imaging made this a truly insightful discussion. Takeaways: 🔵CMR is best at characterizing

Ali Curtis has been named President of MLS NEXT Pro and will oversee all day-to-day aspects of the League's sporting and business operations. He succeeds Charles Altchek, who today MLS named EVP of Club Performance & League Growth. Curtis has also been appointed EVP of MLS

🔎 In symptomatic HCM, obstruction matters—but can be latent. Combining isoproterenol provocation with TEE may unmask LVOTO more sensitively than current approaches. Read more ⬇️ https://t.co/FjhZYaPYWm #CJCO #OpenAccess

@DrEugeneYang @mmartinezheart @jonathankimmd @DreznerJon @BJSM_BMJ @SSharmacardio @eugenechung01 @MJAckermanMDPhD @DrKimHarmon @s_gati @TimChurchillMD @BradleyPetek @DermotPhelanMD @SilCastelletti @DrAneilMalhotra @MichaelPapadak2 Incredible meeting and great group. An honour to be part of it.

Tremendous meeting with close colleagues and friends. Congrats to @DreznerJon for incredible leadership! #IC2025 coming soon. #gamechanger #LFG @BJSM_BMJ @SSharmacardio @mmartinezheart @jessicajorchard @eugenechung01 @MJAckermanMDPhD @DrKimHarmon